Background: Vitamin D status during prenatal brain development may influence risk of attention deficit and hyperactivity disorder (aDHD) symptoms in childhood. However, there are no prospective studies addressing this hypothesis. We aimed to examine whether maternal vitamin D status in pregnancy is associated with risk of aDHD-like symptoms in offspring.
A ttention deficit and hyperactivity disorder (aDHD) is one of the most common neuropsychiatric disorders of childhood, characterized by persistent inattention and/or hyperactivityimpulsivity resulting in substantial functional impairment. in 2011, the centers for Disease control and Prevention estimate that approximately 11% of the US children 4-17 years of age (6.4 million) have been diagnosed with aDHD with increasing rates in the last decade. 1 the etiology of aDHD remains largely unknown. genetic factors are probably the most important determinants of the development of aDHD as revealed by twin, adoption, and molecular genetic studies. [2] [3] [4] Maternal life-style and environmental factors acting in pregnancy-a critical period for brain development-have been proposed as potential triggers of aDHD symptoms in childhood including infections, 5 medication use, 6, 7 environmental contaminants, [8] [9] [10] tobacco smoking and alcohol consumption, 5, 11, 12 and deficiencies in essential vitamins and nutrients. 13 evidence of the presence of vitamin D receptors in the fetal and adult brain in humans has highlighted the potential copyright impact of vitamin D on the development of mental and psychiatric disorders. 14 Vitamin D acting early in life on the developing brain has been related to healthier cognitive and mental phenotypes. Maternal vitamin D status in pregnancy has been associated with improved neuropsychological development in offspring including language, mental, and psychomotor outcomes. 15, 16 Other birth cohort studies have found no association between maternal 25(OH)D serum concentration in pregnancy and offspring behavioral and emotional difficulties through childhood. 15, 17 However, a study assessing autismlike traits showed that offspring of mothers with vitamin D insufficiency [25(OH)D <49 nmol/liter] at 18 weeks of pregnancy were at increased risk for high scores on the attention switching subscale. 18 in addition, cross-sectional studies conducted in children and adolescents have shown lower vitamin D levels in aDHD children compared with children without the disorder. 19, 20 However, a large prospective study found no association of vitamin D status at age 9 years with hyperactivity-inattention problems at age 11 years. 21 to date there are no prospective studies examining the impact of maternal vitamin D status during pregnancy (and thus on the fetus) on the development of aDHD symptoms later in life. We aimed to evaluate whether maternal vitamin D status in pregnancy-estimated by measuring circulating 25-hydroxyvitamin D3 [25(OH)D3] concentration-is associated with risk of aDHD-like symptoms in their children in a population-based cohort study.
METHODS

Study Population
the inMa (infancia y Medio ambiente-environment and childhood) Project is a prospective population-based mother and child cohort study established in several geographic areas in Spain. 22 a total of 3,174 pregnant women who fulfilled the inclusion criteria (i.e., ≥16 years of age, intention to deliver at the reference hospital, no problems of communication, singleton pregnancy, and no assisted conception) were recruited at their first routine specialized antenatal care visit in the main public hospital or health center of reference from five study areas: 530 from the island of Menorca (39°n latitude); 855 from Valencia (39°n latitude); 657 from Sabadell (41°n latitude); 494 from asturias (43°n latitude); and 638 from gipuzkoa (42°n latitude). recruitment was done from February 1997 to September 1998 in Menorca and between november 2003 and February 2008 in the other areas. the study was approved by the ethical committees of the centers involved in the study, and written informed consent was obtained from the parents of all children.
Assessment of Maternal Circulating 25(OH)D3 Concentration
a single maternal blood specimen was drawn during pregnancy (mean [SD] 13.3 [2.9] weeks of gestation). Samples were processed immediately and stored from -70 to -80°c until analysis. Maternal plasma concentrations of 25(OH)D3 were quantified by high-performance liquid chromatography method using a BioraD kit according to clinical and laboratory Standard institute protocols. 23 Detection limit was 5 ng/ml, and interassay coefficient of variation was 4.5%. the assay was validated by german Programmes of external evaluation of Quality (DgKl-rFB-referenzinstitut für Bionalytik), and results were satisfactory in 100% of the cases.
Assessment of Attention Deficit and Hyperactivity Disorder-like Symptoms in Offspring
each child's teacher filled out a questionnaire about aDHD-like symptoms and school performance. the aDHDlike symptoms data were collected using the aDHD criteria of Diagnostic and Statistical Manual of Mental Disorders, fourth edition (aDHD-DSM-iV) form. 24 We used a DSM-iV form as a rating scale without further modifications, which has resulted to be psychometrically useful in a prior validation study comparing parents and teacher reports. 25 the aDHD-DSM-iV is an internationally recognized questionnaire comprising 18 items designed to evaluate attention-deficit (1-9), and hyperactivity-impulsivity (10-18) symptoms in children. each aDHD symptom is rated on a four-point scale (0 = never or rarely, 1 = sometimes, 2 = often, or 3 = very often). We recoded the options 0 and 1 as 0 (symptom absent), and ratings of 2 and 3 as 1 (symptom present). 26 aDHD-DSM-iV scores were treated as categorical and continuous variables. three quantitative traits were generated for use in the association analyses: (1) a count of the number of exhibited hyperactiveimpulsive symptoms, (2) a count of the number of exhibited inattentive symptoms, and (3) a count of the total number of exhibited aDHD-like symptoms. in all three cases, a binary measure indicating the presence or absence of each symptom was measured and the totals were generated by summing over all symptoms, making the maximum number of symptoms 9, 9, and 18, respectively. cronbach's alpha coefficient analyses were 0.90 for general symptoms, 0.88 for attention deficit, and 0.87 for hyperactivity-impulsivity. in addition, children were classified using diagnosis criteria defined by the Diagnostic and Statistical Manual of the american Psychiatric association (fourth edition; DSM-iV; i.e., either or both of following: at least six of nine inattentive symptoms, at least six of nine hyperactive or impulsive symptoms), and the european diagnostic criteria for hyperkinetic disorder (HKD), as defined by the international classification of Diseases (10th edition; icD-10; i.e., all of following: at least six of eight inattentive symptoms, at least three of five hyperactive symptoms, and at least one of four impulsive symptoms). 27
Covariates
Based on previous knowledge, the following were considered a priori potential mediators or confounding factors because of their possible associations with exposure and outcome: child's sex, preterm delivery, child's age at assessment, birth weight, maternal age, parity, maternal country of origin, parental social class, maternal education level, maternal prepregnancy body mass index, maternal smoking and alcohol consumption during pregnancy, breastfeeding duration, and child hours of television viewing. Questionnaires during the first trimester of pregnancy obtained information about parity (0, 1, or more), maternal age at delivery and country of birth (Spanish versus foreign), maternal social class (occupation during pregnancy based on the highest social class by using a widely used Spanish adaptation of the international iScO88 coding system; i-ii, managers/technicians; iii, skilled; iV-V, semiskilled/unskilled), 28 maternal education level (primary or less, secondary, university degree), prepregnancy body mass index based on measured height at recruitment and prepregnancy self-reported weight (kilograms per square meter, kg/m 2 ; underweight [<18.5], normal weight [18.5-24 .99], overweight/obese [≥25]). information on maternal smoking (no versus yes) and alcohol consumption during pregnancy (no versus yes, defined as consumption of alcohol beverages at least 1 time/month) was collected through questionnaires during the third trimester. Detailed information about child feeding through the second year of life was collected from mothers by questionnaires and duration of breastfeeding (defined as receiving any breastmilk, regardless of supplementation with food or other liquids, including nonhuman milk) was categorized into: children who were never breastfed, children who were breastfed for less than 16 weeks, from 16 to 24 weeks, and more than 24 weeks. child television viewing duration measured in hours per week was reported by mothers. all questionnaires were administered face-to-face by trained interviewers. information related to child's sex, birth weight, and gestational age was obtained from clinical records.
Data Analysis
Maternal plasma concentrations of 25(OH)D3 showed a seasonal distribution (eFigure 1; http://links.lww.com/ eDe/a905).to adjust for month at blood collection we used "deseasonalization" of 25(OH)D3 concentrations. Seasonality of 25(OH)D3 was tested by fitting the data to a sine function with a period of 12 months in a nonlinear regression cosinor model. 29 then, the predicted 25(OH)D3 concentrations based on month at blood collection for each subject, derived from the sinusoidal model, were subtracted from the actual observed value. Subsequently, the overall mean was added and the resulting deseasonalized 25(OH)D3 concentrations were analyzed. linear dose-response relation between maternal circulating 25(OH)D3 concentrations during pregnancy and number of aDHD symptoms in children was assessed using adjusted generalized additive models by graphical examination and likelihood ratio test. 30 We ran multivariate negative binomial regression models to examine the association between the number of aDHD symptoms with maternal 25(OH)D3 concentration in pregnancy. global, inattention, and hyperactivity symptoms of aDHD (as defined by the DSM-iV) were treated as quantitative traits. Maternal vitamin D concentration was treated as continuous (effect per 10 ng/ml increment) and as categorical divided into clinically relevant categories (<20 ng/ml [deficiency] [reference group], 20 to 29.9 ng/ml [insufficiency], and ≥30 ng/ml [sufficiency]). the measure of association was the incidence rate ratio (irr) and its corresponding 95% confidence interval (ci), which is a relative measure of the association of maternal 25(OH)D3 concentration with child's aDHD-like symptoms that can interpreted in a similar fashion to an odds ratio. a series of models was run to assess the effect of additionally adjusting (forward selection) one by one each of the individual potential confounders on the coefficient of the main exposure of interest. Variables were retained in the multivariate models only if they showed at least marginally significant association (P < 0.1) or modified the coefficient maternal 25(OH)D3 concentration by at least 5%. Final models were adjusted for area of study, child's sex, child's age at evaluation, and maternal education level. allowance for other possible confounding variables did not materially alter the estimates. in sensitivity analyses, we examined whether associations between maternal 25(OH)D3 and aDHD-like symptoms in children differed by area of study, child's sex, preterm delivery, low birth weight, and maternal educational level and smoking during pregnancy. Finally, to investigate critical periods of susceptibility, we examined whether the associations differed by trimester of pregnancy at 25(OH)D3 measurement (first trimester versus second or third trimesters). analyses were conducted using Stata software, version 12.0 (Statacorp, college Station, tX) and r statistical package version 2.13.0.
RESULTS
One thousand six hundred and fifty eligible motherchild pairs were included in this study (Figure 1 ). the mean age of mothers was 31.9 years. the mean age of offspring at aDHD-like symptoms assessment was 4.8 years. the prevalence of DSM-iV aDHD and icD-10 HKD was 7.2% and 1.9%, respectively. compared with excluded participants, those included in this analysis had higher education level and social class, were breastfed for longer duration, and mothers were older and tended to smoke less during pregnancy, but did not differ on maternal 25(OH)D3 concentration and other characteristics (etable 1; http://links.lww.com/eDe/a905).
Maternal 25(OH)D3 concentration was measured in the first trimester in 300 women (18.3%), in the second trimester in 1,328 (80.8%), and in the third trimester in 15 (0.9%) the median (interquantile range) concentration of maternal circulating 25(OH)D3 was 29.1 ng/ml (21.7, 36.8) . Overall, 19% and 33% of women had deficient (<20 ng/ml) and insufficient (20-29.99 ng/ml) concentration of 25(OH)D3, respectively. Summer season at blood collection, southern latitude of area of study, maternal age, high maternal social class and education level, and percentage of mothers who consumed alcohol in pregnancy all increased linearly from lower to higher maternal 25(OH)D3 categories (etable 2; http://links.lww. com/eDe/a905). a higher number of total aDHD-like symptoms was found among children of Menorca area compared with other areas of study, and among children of mothers that had insufficient 25(OH)D3 in pregnancy (<30 ng/ml) compared with those of mothers with sufficient 25(OH)D3 in pregnancy (≥30 ng/ml; table 1). Males had a higher number of total aDHD-like symptoms compared with females. number of total aDHD-like symptoms increased with child's age and decreased with maternal age. children of mothers with lower social class and educational level showed higher number of aDHD-like symptoms than those of mothers with high social class and educational level. children of overweight and obese mothers scored higher number of total aDHD-like symptoms compared with those of mothers with normal weight. number of total aDHD-like symptoms was higher among children of mothers who smoked in pregnancy compared with nonsmokers and among children not breastfed compared with those breastfed (table 1). children who scored higher number of total aDHD-like symptoms (≥6) reported higher number of hours of tV viewing (mean 11.2 [SD 7.2] hours/week) than those with no aDHD-like symptoms (mean 9.4 [SD 5.7] hours/week; P = 0.003). no associations were found with birth weight, preterm delivery, parity, maternal country of origin, or maternal alcohol consumption in pregnancy. a linear negative relation was found between maternal 25(OH)D3 concentration in pregnancy and number of symptoms in the aDHD global score and in the inattention and hyperactivity-impulsivity subscales (Figure 2 ). after adjustment, number of total aDHD-like symptoms in children decreased by 11% per 10 ng/ml increment of maternal 25(OH) D3 concentration in pregnancy (irr = 0.89; 95% ci = 0.80, 0.98; table 2). Similarly, number of symptoms in the inattention and hyperactivity-impulsivity subscales decreased in relation to higher maternal 25(OH)D3 concentration in pregnancy (irr per 10 ng/ml increment of 25(OH)D3 = 0.89 [95% ci = 0.79, 0.99] for the inattention scale; and irr = 0.88 [95% ci = 0.78, 0.99] for the hyperactivity-impulsivity scale; table 2). compared with children of mothers that had vitamin D deficiency (<20 ng/ml) in pregnancy, children of mothers with vitamin D sufficiency (≥30 ng/ml) had had 23% fewer total aDHD symptoms (irr = 0.77; 95% ci = 0.57, 1.04). Similar associations were found for both aDHD subscales (table 2) .
Using diagnostic criteria, we found an association between increasing maternal 25(OH)D3 in pregnancy and lower risk of DSM-iV aDHD (relative risk ratio per 10 ng/ ml increment = 0.87, 95% ci = 0.72, 1.06) and icD-10 HKD (relative risk ratio = 0.72; 95% ci = 0.49, 1.04; table 3).
the inverse association between maternal 25(OH) D3 concentration in pregnancy and number of aDHD-like symptoms in children was observed across all areas of study (etable 3; http://links.lww.com/eDe/a905). We did not find evidence of different associations for girls and boys, although estimates were slightly stronger in boys than in girls (etable 3; http://links.lww.com/eDe/a905). Similarly, associations were slightly stronger among children of low socioeconomic position (etable 3; http://links.lww.com/eDe/a905). associations remained after restricting the analysis to children whose mothers did not smoke during pregnancy (etable 3; http:// links.lww.com/eDe/a905), excluding preterm deliveries and low birth weight newborns. Decreased risks of aDHD-like symptoms were slightly stronger for 25(OH)D3 concentration in the first trimester compared with second-third trimesters of pregnancy (etable 3; http://links.lww.com/eDe/a905).
DISCUSSION
to the best of our knowledge, this is the first prospective longitudinal cohort study examining the association between maternal vitamin D status in pregnancy-estimated by measuring circulating 25(OH)D3 concentration-with aDHDlike symptoms in childhood. We found higher concentrations of 25(OH)D3 in pregnancy associated with a decreased risk of aDHD symptoms in offspring at ages 4-5 years. in addition, the inverse relationship was also observed among children classified as having DSM-iV aDHD and icD-10 HKD diagnostic criteria.
the observed dose-response relation between maternal 25(OH)D3 concentration in pregnancy and children's aDHD-like symptoms suggests a consistent decrease in the number of aDHD-like symptoms in childhood with increasing concentration of maternal 25(OH)D3 in pregnancy. in addition, these results raise the question of whether it is always necessary to have a cut-off point to separate children with or without aDHD diagnostic criteria in studies of the general population, suggesting the use of a dimensional approach to study aDHD-like symptoms in preschoolers may be more appropriate. 31, 32 to date, no prospective birth cohort study has examined the impact of maternal vitamin D status in pregnancy, a critical period of brain development, on the risk of developing aDHD symptoms in children later in life. Previous birth cohort studies assessing the relation between maternal 25(OH)D status in pregnancy with children's behavioral outcomes have shown inconsistent results. Using data of the australian raine Study, Whitehouse et al. 15 found no association of maternal vitamin D status (~18 weeks gestation) and child behavior using the child Behavior checklist at several ages. in accordance, Keim et al. 17 found no association of maternal (at ≤26 weeks of gestation) or cord blood 25(OH) D with behavior traits between 8 months and 7 years of age. However, in agreement with our results, a second investigation in the raine Study assessing autism-like traits reported increased risk for high scores on the attention-switching subscale in the offspring of mothers with insufficient 25(OH) D at 18 weeks of gestation. 18 Previous epidemiologic crosssectional studies conducted in children have shown lower circulating concentrations of vitamin D in children with aDHD than in children without the disorder. 19, 20 However, a large prospective study assessing circulating 25(OH)D concentration at age 9 years did not find an association with hyperactivity-inattention problems at age 11 years. 21 Differences in study design, instruments used for aDHD evaluation and susceptibility exposure windows make the comparison between studies difficult. given that a growth spurt takes place in the brain from the third trimester of pregnancy through the first 2 years of life, an adequate vitamin D status in pregnant women and young children could likely contribute to reduce the risk of aDHD symptoms later in life. a number of mechanisms could explain the observed associations between maternal vitamin D status in pregnancy and aDHD symptoms in childhood. Vitamin D takes part in important processes for brain development including neuronal differentiation, regulation of reactive oxygen species and neurotrophic factors, and gene expression of mitochondrial, cytoskeletal, and synaptic proteins. 33, 34 antioxidant and anti-inflammatory properties of vitamin D could be of key importance for protecting the developing brain against harmful environmental triggers of human psychiatric disorders including aDHD. to this regard, it has been hypothesized that diverse insults that increase oxidative stress, such as infections, toxins, fever, and inflammation could influence the risk of autism spectrum disorder in vitamin D-deficient pregnant women and young children, 35 which could also be translated to aDHD disorder. Further studies are necessary to increase our understanding of mechanisms linking maternal vitamin D acting on the developing brain to reduced risk of aDHD in childhood.
the main strengths of this study include its populationbased, prospective design and large sample size analyzing data incidence rate ratio and 95% confidence interval from negative binomial regression models. all models adjusted for area of study, child's sex, child's age at evaluation, and maternal education level. a Deseasonalized maternal 25(OHD)D3 concentrations based on month at blood collection for each subject derived from the sinusoidal model. of five birth cohorts set up in different geographical regions of Spain. also, the fact that these cohorts are not from a clinical population increases the potential generalizability of the findings. although the aDHD-DSM-iV instrument used has not yet been validated for preschoolers, it is adequate as reported by their respective teachers, 36 and the internal consistency of outcomes was robust (cronbach's alpha coefficients >0.85). We estimated maternal vitamin D status in pregnancy by measuring circulating 25(OH)D3 concentration a reliable indicator of vitamin D status that also reflects contributions from all sources (i.e., diet and sun exposure). We found an inverse linear relation between maternal circulating 25(OH)D3 and aDHD-like symptoms, including decreased risk of aDHD-like symptoms at concentrations that are considered as sufficient (≥30 ng/ml), 37 which supports the robustness of the findings. Possible confounding was addressed in multivariable analyses adjusted for a wide range of potential confounding factors.
the study has some limitations. First, up to 40% of initially recruited mother-child pairs were excluded from this study; children included had higher education level and social class and were breastfed for longer duration than those excluded. Mothers included were older and tended to smoke less during pregnancy than those excluded, but did not differ on maternal 25(OH)D3 concentration. although these differences may have some impact on the generalizability of results, because maternal 25(OH)D3 concentrations did not differ, it should not affect their internal validity. there is potential for misclassification of aDHD-like symptoms because teachers are not trained examiners; however, it is unlikely to be related to maternal vitamin D status. Furthermore, the DSM-iV form list has been reported to be psychometrically useful in a prior validation study comparing parents and teacher reports. 25 We have found a moderate correlation between mothers and teachers reports in preschoolers 38 as well as predictive associations with later attention function at the age of 11 years. 39 children were examined at 4 years of age, which may be a difficult age for aDHD diagnosis; thus, further studies at older ages when aDHD is established are needed to confirm current findings. Second, only a single 25(OH)D3 measurement per subject was available, which might not reflect maternal long-term status during the entire pregnancy; however, we estimated mean annual circulating 25(OH)D3 concentration from a single measurement to account for seasonal variation and reduce misclassification of the exposure. third, we did not measured circulating 25(OH)D2 concentrations, but, normally, most of the (90%) 25(OH)D is in D3 form. thus, we cannot rule out the possibility that missing information on the maternal 25(OH)D2 status could have resulted into some residual exposure misclassification. However, the proportion of 25(OH)D2 detected is variable. the circulating 25(OH)D2 concentration is normally low or undetectable unless the subject is receiving high amounts in the diet or from supplements. given that, in Spain, food fortification is not mandatory and vitamin D supplement use in pregnancy in our study population was very low (i.e., less than 20% of women reported use of vitamin D supplements and less than 10% took recommended doses of at least 10 mcg of vitamin D from supplements), the impact of misclassification due to failure to assess D2 form should be minimal in these results. Finally, lack of information on parental aDHD symptoms and postnatal child's vitamin D status could have resulted in some residual confounding.
in conclusion, we found that higher concentration of maternal 25(OH)D3 in pregnancy was associated with decreased risk of aDHD-like symptoms in offspring in childhood. these findings suggest that an adequate maternal vitamin D status in pregnancy, and thus fetal vitamin D status, may reduce risk of developing aDHD-like symptoms in childhood. given the high prevalence of vitamin D deficiency among childbearing women, these findings could have important clinical and public health implications. efforts to maintain an adequate vitamin D status in pregnancy could make a positive impact on reducing risk of developing aDHD in childhood if the associations are causal. Further studies are required to confirm the findings and increase our understanding of potential mechanisms. in addition, randomized controlled trials aimed at increasing maternal circulating 25(OH)D3 concentrations in pregnancy would be warranted to see if vitamin D supplementation can reduce risk of aDHD in offspring later in life. relative risk ratio and 95% confidence interval from multinomial regression models. all models adjusted for area of study, child sex, child's age at evaluation, and maternal education level. a estimates per 10 ng/ml increment of deseasonalized maternal 25(OH)D3 concentration. b icD-10 HKD diagnostic criteria: all of the following: at least six of eight inattentive symptoms, at least three of five hyperactive symptoms, at least one of four impulsive symptoms.
